David Shaw’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-30,900
Closed -$2.3M – 4959
2026
Q2
$2.3M Buy
+30,900
New +$2.16M ﹤0.01% 3080

Other funds holding BBIO

David Shaw's BBIO Position: Q3 2026 in Review

David Shaw reduced its BridgeBio Pharma (BBIO) stake by 39% in Q3 2026, selling an estimated $110M and leaving 2,223,190 shares worth $146M. The position accounts for 0.07% of the portfolio, ranked #328.

David Shaw first reported a position in BBIO in Q1 2020 and has held it in 23 quarters since. The position peaked at $271M in Q2 2026. 466 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • David Shaw held 2,223,190 shares of BridgeBio Pharma worth $146M as of Q3 2026.
  • David Shaw sold 1,409,817 BridgeBio Pharma shares in Q3 2026, an estimated $110M.
  • BridgeBio Pharma made up 0.07% of David Shaw's portfolio in Q3 2026, its #328 holding.
  • David Shaw first reported a position in BridgeBio Pharma in Q1 2020 and has held it in 23 quarters since.
  • David Shaw's BridgeBio Pharma position peaked at $271M in Q2 2026.
  • 466 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.